SIG
AGN

Senator Investment Group’s Allergan plc AGN Stock Holding History

Senator Investment Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1,494,300
Closed -$251M – 80
2013
Q4 		$251M Buy
+1,494,300
New +$234M 2.88% 5

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Senator Investment Group's AGN Position: Q2 2019 in Review

Senator Investment Group sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 700,000 shares — an estimated $102M sold.

Senator Investment Group first reported a position in AGN in Q2 2013 and held it in 23 quarters. The position peaked at $607M in Q2 2015. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Senator Investment Group reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Senator Investment Group sold 700,000 Allergan plc shares in Q2 2019, an estimated $102M.
  • Senator Investment Group first reported a position in Allergan plc in Q2 2013 and held it in 23 quarters.
  • Senator Investment Group's Allergan plc position peaked at $607M in Q2 2015.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Senator Investment Group's 13F filing for Q2 2019, filed 14 Aug 2019.